Clinical Trial Update: Effect of an Oral Supplement Enriched in Amino Acids and the Leucine Metabolite B-hydroxy B-methylbutyrate (HMB) [Phase 1]

View source ↗

Summary

A Phase 1 trial of an oral amino acid–enriched supplement containing beta-hydroxy-beta-methylbutyrate (HMB) for pressure ulcers was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pressure Ulcers

Drugs mentioned

• Oral amino acid–enriched supplement with HMB (beta-hydroxy-beta-methylbutyrate)

Snippet

Sponsor: Central Arkansas Veterans Healthcare System | Conditions: Pressure Ulcers | Phase 1 | Status: TERMINATED